coastalowl80 said:I have allergic asthma.
I’m wondering if any of you have experience with this, if you know anything more about it, or what you would recommend?
From what I’ve gathered, a handful of people dealing with severe asthma and allergies to basically everything living were part of a clinical trial for a new drug over at the University of California Medical Center in Chicago. I’ve been trying to get my hands on it myself—but honestly, there's zero chance until the end of September. I am absolutely certain—and I mean, mark my words, absolutely CERTAIN—that ENKORTEN is the ONLY thing that can help. They've been testing it there, and starting in September, it should be added to their asthma treatment list.
Try to find a way to contact the head of the clinic, Dr. Hasan Žutić, or maybe the chief physician Pećanac, to see how this new medication actually works. From what I understand, it targets the immune system by boosting immunity—which is the key—and most importantly, it's easy on the body. It supposedly has no side effects, which is exactly what I need because those corticosteroids are absolutely destroying me.
It looks like they are developing it in collaboration with the USA and Germany.
For more info, you should look into the Mayo Clinic (specifically the pulmonary department at the University of California Medical Center).
On the Pfizer website, there's just a mention that they are currently in Phase III clinical trials for asthma, and it seems like they are coordinating the research—though I don't have all the granular details.
That also means we're nearing the finish line. The only potential catch is that the drug is administered via subcutaneous injection three times a week during the initial phase (so, you really have to be physically present there at the start).
Also, I'm not sure if you're an adult, because being of legal age is usually one of the requirements for these things.
We really need to see if they publish the Phase II results involving those 60 asthma patients on their website; that data is going to be crucial.
I hope I've pointed you in the right direction.🙂 :klap: